AKT1 and head and neck squamous cell carcinoma: The HNSCC cell lines used in this study, FaDu, Cal-27, and SCC-25 all expressed the activated form of Akt (pAkt, Figure 1), which was inhibited by 24 hours treatment with 5 μM PER.